# Association between neutrophil to lymphocyte ratio and the risk of vertebral fracture in patients with osteoporosis: a systematic review and meta-analysis

**Authors:** Dezhi Xu, Jiaxin Wang

PMC · DOI: 10.3389/fendo.2026.1739898 · Frontiers in Endocrinology · 2026-02-18

## TL;DR

This study finds that higher neutrophil-to-lymphocyte ratios may be linked to increased vertebral fracture risk in osteoporosis patients, but results are unstable and need more research.

## Contribution

This is the first systematic review and meta-analysis to evaluate NLR as a potential biomarker for vertebral fractures in osteoporosis.

## Key findings

- High NLR groups had significantly increased vertebral fracture risk (OR = 3.75).
- Excluding one study made continuous data significant (SMD = 0.27) with reduced heterogeneity.
- NLR shows potential as an inflammation-related biomarker but requires further validation.

## Abstract

Vertebral fractures, which account for 40% of osteoporotic fractures, often lack early clinical symptoms. Previous studies have shown that neutrophil-to-lymphocyte ratio (NLR) has potential predictive value for vertebral fractures, but evidence-based conclusions are lacking. This meta-analysis is the latest to evaluate the link between NLR and vertebral fracture risk in patients with osteoporosis.

We systematically searched PubMed, Embase, Web of Science, Cochrane, Wanfang and CNKI (up to March 2025). The search was performed using the following keywords: “Neutrophils”, “Lymphocytes”, “Osteoporosis”, and “Fracture”. Odds ratio (OR) and standardized mean difference (SMD) with 95% confidence intervals (CIs) were used for the data synthesis of categorical and continuous variables, respectively. Sensitivity analysis was performed to explore the stability of the results and possible sources of heterogeneity. All analyses were performed using Review Manger 5.4 and STATA 15.0.

Six observational studies (n=938) were included. Categorical data showed a significantly higher vertebral fracture risk in high-NLR groups (OR = 3.75, 95% CI:1.79-7.86; P = 0.0005). However, continuous data revealed no significant NLR difference between fracture and non-fracture groups (SMD = 0.51, 95% CI: -0.06-1.08; P = 0.08). Sensitivity analysis revealed that when the data of Li et al., 2023 were excluded, the results of continuous data shifted from insignificant to significant (SMD: 0.27; 95% CI: 0.08, 0.46; P = 0.004), and the heterogeneity decreased significantly.

Higher NLR values ​​in osteoporotic patients are significantly associated with an increased risk of vertebral fractures, but the strength of this evidence is limited by high heterogeneity and the instability of results from continuous variables. Current findings support NLR as a potential inflammation-related biomarker for vertebral fractures, but its clinical application requires careful interpretation. Future research should focus on conducting more high-quality, large-sample prospective studies to standardize NLR thresholds and validate its practical value in risk stratification for osteoporotic fractures.

https://www.crd.york.ac.uk/PROSPERO/view/, identifier CRD420251023391.

## Linked entities

- **Diseases:** osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}
- **Diseases:** inflammation (MESH:D007249), NLR (MESH:D015467), Bone Fracture (MESH:D050723), skeletal disorder (MESH:C564967), lung cancer (MESH:D008175), diabetes (MESH:D003920), lymphopenia (MESH:D008231), malignant tumors (MESH:D009369), chronic kidney disease (MESH:D051436), osteoporotic (MESH:D058866), bone metabolic abnormalities (MESH:D001851), acute appendicitis (MESH:D001064), neutropenia (MESH:D009503), death (MESH:D003643), colorectal cancer (MESH:D015179), hip fracture (MESH:D006620), cardiovascular disease (MESH:D002318), Vertebral fractures (MESH:C535781), Osteoporoses (MESH:D010024), ulcerative colitis (MESH:D003093)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956537/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956537/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956537/full.md

---
Source: https://tomesphere.com/paper/PMC12956537